Angiogenesis pioneer dies

Article

Judah Folkman, MD, the pioneer of angiogenesis research, died on January 15th 2008.

Judah Folkman, MD, the pioneer of angiogenesis research, died on January 15th 2008.

Dr Folkman was the 2006 recipient of the Helen Keller Prize for Vision Research. His 1971 hypothesis, that solid tumours are angiogenesis-dependent, led researchers to the first angiogenic inhibitor for age-related macular degeneration (AMD), laying the groundwork for drugs such as Lucentis and Macugen.

Thanks to Dr Folkman, ten new cancer drugs are on the market and people who might otherwise be blind have been given a lifeline.

Related Videos
Ana Neves, head of global marketing for ZEISS Meditec Ophthalmology
Fritz Hengerer, MD, PhD, Director, Eye Hospital at Bürgerhospital, Frankfurt, Germany
Dr Sheng Lim, professor of glaucoma studies at St Thomas' Hospital, London
Kasperi Kankare at the iCare booth at ESCRS
Scott D Barnes, MD, CMO of STAAR Surgical
Tomislav Bucalic, head of marketing at Geuder, and David Geuder, member of the executive board and CIO
Related Content
© 2023 MJH Life Sciences

All rights reserved.